Reply  by Martin, Gerard R.
1.350 LElTERS l-0 THE ELXTOR 
7be authors may mean that a single cardiac tumor may be benign 
and mmssociated with tubetose sclerosis or that tumors may be 
cardiity benign because most tumors regressed spontaneously 
or did not require treatment, but they do not say that. Their conclusion 
is therefore misleading and inappropriate. 
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cardiac tumor wbo may not develop tuberous sciemsis is an equally 
significant event. 
Assessing the Significance of 
Preinfarction Angina 
With regard to the letter by Aban concerning the conclusions of our 
report (1). I do not feel that our conciustons arc misleading or 
inapprotniate; rather, Atlan has simply misinterpreted our intended 
context of the word “benign.” 
This huge, retmspective, multiu‘nter study was intended to provide 
epidemio~c information about the disgnosis and management of 
fetal cardii trmmrs. Given the retrospective nature of the study. II I 
not surprisii Atlan notes that some data were not available rar each 
case. Despite these timitations, which were addressed in the di;cuGxt, 
the proportion of fetal patients with tubemus sclerosis and fetal 
tumors was similar to that reported in other peliatric studii (50%). 
The term “benign” was used twice in our report, once in the 
abstract and once in the discussion. In the abstract the contest of the 
word “beatii” refets to tissue type of tumors of 19 tumors discev- 
ered, 17 were rhabdomycenas, a benign tumor. The other IWO tumors 
were not benign-a tibroma that infiltrated throughout much of the 
heart and an atrial hemangioma. In thin mntext, “benign” is neither 
misbding nor &mate. 
In the d&usGn, ?senign” does indeed, and was intended to, refer 
tooutcome. 1 have no prmblem in stating that fetal cardiac tumors “can 
behave in a benign fash&” Not all rumors required intervention; 
some tumors spontaneo4y involuted; and not all patients with tumors 
had tthmus schosis (as in Abn’s personal experience). In fa& as 
Alian 00% out data suggesl that sin& ttmsors are rarety associated 
with tttberotts sderosis; a tinding ditferent from that reported previ- 
o&y (2). This point is further daritied in the tinat sentence of the 
report, which states “therefore, counseTmg of families where singte 
cardiac~ispresentmaybemoreoptimist.ic.” 
I am all tou concerned that physickms performing fetal echocardi- 
onthebasisofanincompleteknowl- 
the published reports. This goint was 
pt+n& made in an editorial by H&a (3). Our multicenter study 
also higftliib the imptam. of completing our knowiedge base of 
fetal diseas before recommending thempies as signi6cant as fetal 
tionofpKgnanq.Thereisnodo~rutattuberous 
a dewastatmg effed on chiien and their famitii 
~~t~~ofa~~~a~~~~asi~ 
Tbc report by Anrai et al. (I) in a recent tssue of tbe Journal concluded 
that patients with ;xeinfarction angina pectoris have a more favorable 
short- and long-term prognosis after hospital admission for acute 
myocardial infarction. This is in contrast to previous studies eaamining 
the issue, which have found that patients with a history of angina 
actually have a worse short- and long-term pmgncsis after a myocar- 
dial infarction (Z-5). As poinicd out in the report by Anzai et al., the 
majority of previous studies did not control for confounding variables. 
such as prior myocardial infarction, severity of coronary disease, signs 
of heart failure and infarction location. In an attempt to overcome 
these limitations, Anmi et al. (1) limited their study population to 
patients without a history of prior infarction and controlled for 
mrmemus confounding variables The authors concluded that 1) prein- 
farction angina is an independent predictor of decreased in-hospital 
mortality, and 2) in patients with an acute anterior infarction, preinfarc- 
tion angina is asxciated with a lauer incidence of cudii rupture, 
ventriadar aneurysm formation and readmiiion for heart failure. They 
hypothesized that tbe benebcial effect of preinfarction angina occurred 
from infarct she limitation passibb secondary to ischcmic preconditioning 
(1). 
Although the patients with and those without a history of angina 
appeared to be we1 matched with respect to age, gender and cardiac 
risk factors, an alternative exptanation for the beneficial effects of 
-gina observed in this study is that preinfarction angisa is a marker 
for a confounding factor that w&s not measured. such as aspirin use. 
The investigators controlled for numerous mediitions, including the 
use of thrombotybk therapy, beta-adrenergic blocking agents, calcium 
antagonists and angiotensin-converting enzyme inhibitors but surpris- 
ingly failed to control for aspirin use. It is quite plausibte that patients 
who developed angina before their first myocardial iofarciion were 
more likely to be taking aspirin. 
In a recent study, Garcia-Dorado et al. (6) prospectively evaluated 
the et&t of previous aspirin use in patients prese .ing with acute 
ischemic syndromes. Tbey found that previous aspirin use was asaoci- 
atedwithashattwvardalesssevereclinical~aodthatinthe 
subset of patients wbo devetoped a myocardial infarction, prior aspirin 
tse was amcxiated with a 38% reduction in peak ueatine kinase (CX). 
